+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

Interstitial Lung Disease Market Report 2026 - Product Thumbnail Image

Interstitial Lung Disease Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Pharyngitis Treatment Market Report 2026 - Product Thumbnail Image

Pharyngitis Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
From
Idiopathic Pulmonary Fibrosis Market Report 2026 - Product Thumbnail Image

Idiopathic Pulmonary Fibrosis Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Acute Ischemic Stroke Diagnosis Market Report 2026 - Product Thumbnail Image

Acute Ischemic Stroke Diagnosis Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Diabetic Neuropathy Market Report 2026 - Product Thumbnail Image

Diabetic Neuropathy Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Cytomegalovirus (CMV) Therapeutics Market 2026-2030 - Product Thumbnail Image

Cytomegalovirus (CMV) Therapeutics Market 2026-2030

  • Report
  • January 2026
  • 289 Pages
  • Global
From
From
Cutaneous Squamous Cell Carcinoma- Pipeline Insight, 2025 - Product Thumbnail Image

Cutaneous Squamous Cell Carcinoma- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 120 Pages
  • Global
From
From
From
From
Loading Indicator